2020
DOI: 10.1016/j.chest.2020.08.1543
|View full text |Cite
|
Sign up to set email alerts
|

Correlation of 6-Minute-Walk Test With Functional Profile in Stable Patients With Copd

Abstract: To study the correlation of six minute walk test, a simple test with spirometry and clinical and radiological parameters in COPD patients. PRIMARY OBJECTIVE-To assess severity in correlation of six minute walk test spirometric and radiological findings in COPD patients. SECONDARY OBJECTIVE-To correlate six minute walk test with clinical parameters. METHODS: A hospital based prospective cross sectional study was done on 100 COPD patients attending department of respiratory medicine, Institute of respiratory dis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…The 6-min walk test (6MWT) is a submaximal, simple, low-cost, and effective exercise test used to obtain the functional capacity of patients with moderate to severe cardiopulmonary disease (Solway et al, 2001;American Thoracic Society, 2002). The 6min walk distance (6MWD) is one of the key observations in clinical trials, and can be used as a predictor of diagnosis, prognosis and survival of patients with cardiopulmonary diseases, such as chronic obstructive pulmonary disease (COPD) (Casanova et al, 2008;Dajczman et al, 2015;Meena et al, 2020), interstitial lung diseases (Brown and Nathan, 2018), pulmonary hypertension (Farber et al, 2015;Gadre et al, 2017) and lung transplant (Castleberry et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…The 6-min walk test (6MWT) is a submaximal, simple, low-cost, and effective exercise test used to obtain the functional capacity of patients with moderate to severe cardiopulmonary disease (Solway et al, 2001;American Thoracic Society, 2002). The 6min walk distance (6MWD) is one of the key observations in clinical trials, and can be used as a predictor of diagnosis, prognosis and survival of patients with cardiopulmonary diseases, such as chronic obstructive pulmonary disease (COPD) (Casanova et al, 2008;Dajczman et al, 2015;Meena et al, 2020), interstitial lung diseases (Brown and Nathan, 2018), pulmonary hypertension (Farber et al, 2015;Gadre et al, 2017) and lung transplant (Castleberry et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…The 6-min walk test (6MWT) is a submaximal, simple, low-cost, and effective exercise test used to obtain the functional capacity of patients with moderate to severe cardiopulmonary disease ( Solway et al, 2001 ; American Thoracic Society, 2002 ). The 6-min walk distance (6MWD) is one of the key observations in clinical trials, and can be used as a predictor of diagnosis, prognosis and survival of patients with cardiopulmonary diseases, such as chronic obstructive pulmonary disease (COPD) ( Casanova et al, 2008 ; Dajczman et al, 2015 ; Meena et al, 2020 ), interstitial lung diseases ( Brown and Nathan, 2018 ), pulmonary hypertension ( Farber et al, 2015 ; Gadre et al, 2017 ) and lung transplant ( Castleberry et al, 2017 ).…”
Section: Introductionmentioning
confidence: 99%